SCHEMBL30033897

SCHEMBL30033897

Cn1ncc2c(NCc3ccc(S(N)(=O)=O)cc3)nc(N3CCCCC3)nc21

nearest known ligand 0.53

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ HTR2C P28335 6/20 0.53
▸ PDE2A O00408 2/20 0.48
▸ PIK3CA P42336 1/20 0.47
▸ BCDIN3D Q7Z5W3 8/20 0.45
▸ HRH1 P35367 1/20 0.43
▸ HRH4 Q9H3N8 1/20 0.43
▸ CA1 P00915 1/20 0.42
▸ CA2 P00918 1/20 0.42
▸ CA9 Q16790 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23579785 1.00 HTR2C (0.53) HTR2CPDE2APIK3CABCDIN3DHRH1
SCHEMBL30034965 0.92 HTR2C (0.53) HTR2CPDE2ABCDIN3DHRH1HRH4
SCHEMBL23579669 0.92 HTR2C (0.53) HTR2CPDE2ABCDIN3DHRH1HRH4
SCHEMBL23598905 0.90 HTR2C (0.54) HTR2CPDE2APIK3CABCDIN3DCA1
SCHEMBL30034770 0.90 HTR2C (0.54) HTR2CPDE2APIK3CABCDIN3DCA1
SCHEMBL13943266 0.86 HTR2C (0.58) HTR2CPDE2APIK3CABCDIN3DHRH1
SCHEMBL13944350 0.85 PDE2A (0.68) HTR2CPDE2APIK3CABCDIN3DHRH1
SCHEMBL13944731 0.85 HTR2C (0.72) HTR2CPDE2APIK3CAHRH4
SCHEMBL3644693 0.83 HTR2C (0.58) HTR2CPDE2APIK3CABCDIN3DHRH1
SCHEMBL23579797 0.82 PDE2A (0.55) PDE2ABCDIN3DCA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115151550-B External nucleotide pyrophosphatase/phosphodiesterase 1 (ENPP 1) modulators and uses thereof 桑福德·伯纳姆·普雷比医学发现研究所 2024-11-22 — — CN disclosed
EP-4081528-A1 ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE 1 (ENPP1) MODULATORS AND USES THEREOF Sanford Burnham Prebys Medical Discovery Institute (US) 2022-11-02 — — EP disclosed
Send feedback